About Digestive Cancer LuxembourgTrusted information.
Patient voices.
Meaningful progress.
An independent, patient-led non-profit organisation based in Luxembourg, created to improve understanding of digestive cancers through education, advocacy and collaboration.
Who We AreFounded by a patient, for patients.
I’m Gilly Mathieson, founder and Chair. I spent 15 years as a BBC journalist and documentary filmmaker, then moved to Luxembourg with my four young children and in 2013 began working as Communications Manager for Luxembourg for Finance.
In 2019, at the age of 47, I was diagnosed with stage IV early-onset colon cancer. I was told it was inoperable and incurable, and my tumour carried a KRAS G12D mutation, which meant very limited treatment options.
Four rounds of chemotherapy did not shrink the tumours. I translated my own medical notes, wrote to specialists myself for second opinions and organised my own surgery. No surgeon in Luxembourg could perform the operation, so with the support of my Luxembourg oncologist, the CNS approved my treatment abroad (an S2 authorisation). A surgical team in Freiburg, Germany, was the only one willing to attempt the operation that gave me the best chance: removing the cancer from my colon and liver at the same time. I had tumours in seven of the eight segments of my liver, one just 1 mm from a major blood vessel. The surgery took nine hours, 77% of my liver was removed, and I spent three months in hospital.
After a further 13 rounds of chemotherapy, which had been delayed for four months because I was critically ill, I had progression with new metastases in my liver and underwent another liver resection. It then spread to my lungs.
I volunteered tumour samples for research and took part in a tumour profiling study at Luxembourg’s National Health Laboratory (LNS). Testing my cancer cells showed that chemotherapy was ineffective, leaving surgery as my only treatment option. Tissue from my operations in Germany was donated to a German biobank. After two lung operations, this helped me access a study at the National Center for Tumor Diseases (NCT) in Heidelberg that included a personalised neoantigen cancer vaccine.
I continue to receive experimental treatment in Heidelberg. So far, it is working and keeping the cancer in check. I live with stage IV cancer as a chronic disease. Like many people with advanced cancer, I also lost my job and financial security.
For four years, I have been a volunteer patient advocate with Digestive Cancers Europe, and I am a member of Cancer Patients Europe. For several years, I have also volunteered as a patient partner in Luxembourg’s National Cancer Plan sessions on how a cancer diagnosis is announced to patients (l’annonce du diagnostic). I qualified as a patient advocate through VOICE at Barts Cancer Institute and completed EUPATI’s 14-month Patient Expert Training Programme, covering medicines development, clinical trials, regulatory affairs and health technology assessment. I have attended the ESMO Congress, including Digestive Cancers Europe masterclasses held at ESMO. I am a keynote speaker at international events, including the 2025 Global Forum in Glasgow, co-hosted by the Scottish Government and Sprink, and the 2025 Conquering Cancer Forum, part of London Life Sciences Week.
I founded Digestive Cancer Luxembourg with my daughter Hudson and Joachim, whom I met while working at Luxembourg for Finance, so that no one in Luxembourg has to work it all out alone.
Our board
Gilly Mathieson, Founder and Chair
Former BBC journalist and documentary filmmaker, EUPATI Fellow, living with stage IV colon cancer.
Dr Joachim Beckert, Treasurer
Joachim is the former CEO of UniCredit International Luxembourg. He holds a doctorate in economics from LMU München and is an Officier de l’Ordre de Mérite du Grand-Duché de Luxembourg.
Hudson Howarth, Board Member
Hudson is Luxembourgish and studies Chemistry with Medicinal Chemistry at the University of Warwick. She was 14 when her mother was diagnosed, and brings a young carer’s experience and fluent Luxembourgish, French, German and English.
Our MissionMake trusted information accessible.
Our mission is to improve health literacy, encourage earlier diagnosis and help people understand the rapidly changing landscape of digestive cancer care.
Our VisionA better-informed digestive cancer community.
We imagine a future where patients, families, professionals and policymakers are better connected, better informed and better equipped to drive progress.
Why we existEvery diagnosis comes with questions.
Digestive cancer changes lives, but understanding should not feel impossible. People need clear language, trustworthy guidance and information that respects both the science and the human experience.
Digestive Cancer Luxembourg was created to help close that gap by combining education, evidence-based information, storytelling, advocacy and collaboration.
What Guides UsCalm, credible and patient-centred by design.
Awareness
Raising public understanding of digestive cancers, symptoms, screening and prevention.
Navigation
Helping people find clear information and feel less overwhelmed by complex medical topics.
Advocacy
Supporting better dialogue, inclusion and patient-centred change.
Collaboration
Bringing together patients, families, professionals, researchers and policymakers.
Education
Sharing evidence-based information in language that feels clear and accessible.
Hope
Creating a thoughtful space for progress, connection and informed action.
TogetherWe inform. We empower.
We connect. We advocate.
Get in touch, join our newsletter or learn how to support Digestive Cancer Luxembourg’s mission.